DAMORA THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $-33.8M | $31.1M |
| Jun 2019 | — | $-41.9M | — |
| Sep 2019 | — | $-48.1M | $14.7M |
| Dec 2019 | — | $-71.1M | $11.3M |
| Mar 2020 | — | $-77.0M | $42.8M |
| Jun 2020 | — | $-82.6M | $35.8M |
| Sep 2020 | — | $-91.7M | $85.3M |
| Dec 2020 | — | $165.5M | $163.6M |
| Mar 2021 | — | $152.6M | $74.3M |
| Jun 2021 | — | $141.4M | $68.6M |
| Sep 2021 | — | $129.6M | $66.2M |
| Dec 2021 | — | $117.2M | $62.6M |
| Mar 2022 | — | $101.3M | $45.4M |
| Jun 2022 | — | $85.1M | $29.8M |
| Sep 2022 | — | $72.7M | $28.3M |
| Dec 2022 | — | $61.8M | $32.8M |
| Mar 2023 | — | $50.3M | $25.1M |
| Jun 2023 | — | $43.7M | $23.0M |
| Sep 2023 | — | $37.4M | $23.1M |
| Dec 2023 | — | $32.3M | $21.5M |
| Mar 2024 | — | $28.2M | $21.1M |
| Jun 2024 | — | $23.6M | $22.9M |
| Sep 2024 | — | $20.9M | $19.7M |
| Dec 2024 | — | $15.8M | $14.2M |
| Mar 2025 | — | $13.7M | $11.9M |
| Jun 2025 | — | $11.0M | $10.2M |
| Sep 2025 | — | $8.0M | $7.6M |
| Dec 2025 | — | $240.4M | $257.6M |
| Mar 2026 | — | $511.6M | $532.9M |
| Jun 2026 | — | $516.1M | $540.5M |